The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)
The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)
批准号:
10266149
负责人:
Charles DeCarli
金额:
$1321.22万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-30 至 2027-08-31
关键词:
AddressAfrican AmericanAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer’s disease biomarkerAmericanAmyloidAwarenessBiological MarkersBloodBlood VesselsBrainCaringCensusesCharacteristicsClinicalClinical assessmentsCognitionCognitiveDataDementiaElderlyEpidemiologyEthnic OriginEvolutionFutureGenetic Predisposition to DiseaseGoalsHealthHispanicsImpaired cognitionIndividualInfarctionInflammationKnowledgeLesionLifeLocationMagnetic Resonance ImagingMeasuresMediatingMedicalMemoryMicrovascular DysfunctionMinorModelingNerve DegenerationOutcomePF4 GenePathologyPatientsPlayPopulationPopulation HeterogeneityProcessPublic HealthRaceRiskRisk FactorsRoleStrokeTherapeutic StudiesVascular Cognitive ImpairmentVascular DiseasesWaterWhite Matter Hyperintensitybasebrain healthcerebrovascularclinical phenotypeclinically significantcognitive performancecohortdementia riskeffective therapyendothelial dysfunctionexecutive functioninclusion criteriainflammatory markerinjury burdenneuroimagingnon-dementednovelnovel markerpolygenic risk scoreprecision medicineradiologistrisk prediction modelscreeningsexvascular risk factorwhite matterwhite matter injury
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – Overall
Initially identified on MRI in 1986 as “…incidental lesions of uncertain clinical significance associated with
cerebrovascular risk factors”, white matter hyperintensities (WMH) are a common consequence of the aging
process exacerbated by vascular risk factors. WMH also influence cognition and evolution of WMH are
associated with declines in both memory and executive function while extensive WMH predict incident MCI,
stroke and dementia. WMH and infarction also have a negative impact on cognition independent or in addition
to concurrent amyloid status. The impact of WMH is consistent with evidence that clinical dementia is a
multifactorial processes. The impact of WMH on dementia is also consistent with the fact that dementia risk
scales emphasize the role of vascular risk in dementia prediction.
As the US population becomes increasingly older and more diverse, the number of Americans with dementia is
expected to rise substantially, particularly for those with concomitant vascular disease. Importantly, the impact
of vascular disease on dementia risk may be exacerbated in African Americans and Hispanics, who are at
greater risk for vascular disease and for whom vascular disease may play a larger role in clinical dementia.
As awareness of dementia increases, it is becoming common to see individuals presenting for clinical
assessment with minor cognitive complaints. Neuroimaging studies frequently identify “incidental” WMH,
usually ascribed to “microvascular disease” by radiologists, raising patient concerns about their brain health
and future risk for dementia. To date, however, we are not aware of any studies that have
comprehensively examined the impact of individual and combined MRI measures of white matter injury
on cognitive performance among a diverse, non-demented, stroke free population with cognitive
complaints over an extended period of observation. To address this important gap in scientific knowledge,
we propose the following aims:
Aim 1. To identify the extent and characteristics of white matter injury that influence cognitive and health
outcomes
Aim 2. Evaluate Mechanisms of progression of White Matter (WM) Injury on Cognition and Health Outcomes
Aim. 3. Based on findings from Aims 1 and 2, build and validate a predictive risk model with the ultimate goal of
increasing the understanding of precision medical management and planning needed by patients with white
matter lesions, both for need for care as was inclusion criteria for future therapeutic studies.
Impact: Given recent data showing that the impact of vascular risk factors on dementia can be modified by
effective treatment in later life potentially lessening population burden of dementia, developing strategies that
recognize and precisely treat the contribution of VCID to dementia burden is a public health imperative.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Do Atmospheric Ultrafine Particles Lodge in the Brain and Cause Cognitive Decline Leading to Alzheimer's Disease Related Dementias?
-
批准号:10591354
-
项目类别:
-
资助金额:$209.43万
-
财政年份:2022
-
负责人:Charles DeCarli
-
依托单位:
Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease
-
批准号:10629449
-
项目类别:
-
资助金额:$576.35万
-
财政年份:2022
-
负责人:Charles DeCarli
-
依托单位:
Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease
-
批准号:10370841
-
项目类别:
-
资助金额:$667.95万
-
财政年份:2022
-
负责人:Charles DeCarli
-
依托单位:
Early and life course socioeconomic adversity and dementia risk in Hispanics/Latinos
-
批准号:10445900
-
项目类别:
-
资助金额:$144.18万
-
财政年份:2022
-
负责人:Charles DeCarli
-
依托单位:
Early and life course socioeconomic adversity and dementia risk in Hispanic/Latinos
-
批准号:10831329
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2022
-
负责人:Charles DeCarli
-
依托单位:
Administrative Core
-
批准号:10461121
-
项目类别:
-
资助金额:$54.1万
-
财政年份:2021
-
负责人:Charles DeCarli
-
依托单位:
UC Davis Alzheimer's Disease Research Center
-
批准号:10461120
-
项目类别:
-
资助金额:$317.86万
-
财政年份:2021
-
负责人:Charles DeCarli
-
依托单位:
UC Davis Alzheimer's Disease Research Center
-
批准号:10666428
-
项目类别:
-
资助金额:$318.85万
-
财政年份:2021
-
负责人:Charles DeCarli
-
依托单位:
Neuroimaging Core
-
批准号:10461128
-
项目类别:
-
资助金额:$20.69万
-
财政年份:2021
-
负责人:Charles DeCarli
-
依托单位:
Neuroimaging Core
-
批准号:10666453
-
项目类别:
-
资助金额:$20.75万
-
财政年份:2021
-
负责人:Charles DeCarli
-
依托单位:
Administrative Core
-
批准号:10666429
-
项目类别:
-
资助金额:$54.27万
-
财政年份:2021
-
负责人:Charles DeCarli
-
依托单位:
UC Davis Alzheimer's Disease Research Center
-
批准号:10264660
-
项目类别:
-
资助金额:$312.92万
-
财政年份:2021
-
负责人:Charles DeCarli
-
依托单位:
Neuroimaging Core
-
批准号:10264667
-
项目类别:
-
资助金额:$20.36万
-
财政年份:2021
-
负责人:Charles DeCarli
-
依托单位:
Administrative Core
-
批准号:10264661
-
项目类别:
-
资助金额:$53.25万
-
财政年份:2021
-
负责人:Charles DeCarli
-
依托单位:
UC Davis Alzheimer's Disease Core Center
-
批准号:10012518
-
项目类别:
-
资助金额:$6.99万
-
财政年份:2020
-
负责人:Charles DeCarli
-
依托单位:
The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)
-
批准号:10489289
-
项目类别:
-
资助金额:$950.31万
-
财政年份:2020
-
负责人:Charles DeCarli
-
依托单位:
Administrative Core
-
批准号:10266150
-
项目类别:
-
资助金额:$881.34万
-
财政年份:2020
-
负责人:Charles DeCarli
-
依托单位:
Administrative Core
-
批准号:10489290
-
项目类别:
-
资助金额:$342.78万
-
财政年份:2020
-
负责人:Charles DeCarli
-
依托单位:
Novel imaging and endothelial biomarkers of small vessel cerebrovascular disease
-
批准号:9356355
-
项目类别:
-
资助金额:$101.63万
-
财政年份:2016
-
负责人:Charles DeCarli
-
依托单位:
Novel imaging and endothelial biomarkers of small vessel cerebrovascular disease
-
批准号:9768246
-
项目类别:
-
资助金额:$118.47万
-
财政年份:2016
-
负责人:Charles DeCarli
-
依托单位:
海外基金